Oppenheimer Asset Management Inc. Amgen Inc Transaction History

Oppenheimer Asset Management Inc.

$8.04 Billion
Q3 2024

A detailed history of Oppenheimer Asset Management Inc. transactions in Amgen Inc stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 5,099 shares of AMGN stock, worth $1.34 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

5,099

Previous 5,857 12.94%

Holding current value

$1.34 Million

Previous $1.83 Million 10.27%

% of portfolio

0.02%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$309.38 - $337.38 $234,510 - $255,734	-758 Reduced 12.94%	5,099 $1.64 Million
Q2 2024 Aug 08, 2024	SELL	$262.75 - $319.31 $1.88 Million - $2.29 Million	-7,164 Reduced 55.02%	5,857 $1.83 Million
Q1 2024 May 06, 2024	SELL	$268.87 - $324.56 $436,107 - $526,436	-1,622 Reduced 11.08%	13,021 $3.7 Million
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $495,290 - $558,747	-1,937 Reduced 11.68%	14,643 $4.22 Million
Q3 2023 Nov 07, 2023	BUY	$218.65 - $271.46 $72,591 - $90,124	332 Added 2.04%	16,580 $4.46 Million
Q2 2023 Aug 02, 2023	SELL	$214.27 - $253.37 $19,070 - $22,549	-89 Reduced 0.54%	16,248 $3.61 Million
Q1 2023 May 10, 2023	BUY	$225.79 - $275.2 $221,499 - $269,971	981 Added 6.39%	16,337 $3.95 Million
Q4 2022 Feb 06, 2023	BUY	$229.03 - $291.01 $99,169 - $126,007	433 Added 2.9%	15,356 $4.03 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $467,774 - $527,564	2,084 Added 16.23%	14,923 $3.36 Million
Q2 2022 Aug 08, 2022	BUY	$230.71 - $256.74 $207,408 - $230,809	899 Added 7.53%	12,839 $3.12 Million
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $252,160 - $278,955	1,150 Added 10.66%	11,940 $2.89 Million
Q4 2021 Feb 02, 2022	SELL	$198.88 - $227.6 $301,502 - $345,041	-1,516 Reduced 12.32%	10,790 $2.43 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $1.74 Million - $2.04 Million	-8,220 Reduced 40.05%	12,306 $2.62 Million
Q2 2021 Aug 03, 2021	BUY	$233.58 - $259.14 $180,557 - $200,315	773 Added 3.91%	20,526 $5 Million
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $408,758 - $476,341	1,842 Added 10.28%	19,753 $4.92 Million
Q4 2020 Feb 11, 2021	SELL	$216.38 - $257.67 $5.74 Million - $6.84 Million	-26,531 Reduced 59.7%	17,911 $4.12 Million
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $560,578 - $623,409	-2,389 Reduced 5.1%	44,442 $11.3 Million
Q2 2020 Aug 11, 2020	BUY	$197.81 - $242.74 $69,233 - $84,959	350 Added 0.75%	46,831 $11 Million
Q1 2020 May 08, 2020	BUY	$182.24 - $241.7 $2.24 Million - $2.97 Million	12,278 Added 35.9%	46,481 $9.42 Million
Q4 2019 Feb 07, 2020	BUY	$189.21 - $243.2 $110,687 - $142,272	585 Added 1.74%	34,203 $8.25 Million
Q3 2019 Oct 31, 2019	SELL	$174.11 - $208.62 $124,314 - $148,954	-714 Reduced 2.08%	33,618 $6.51 Million
Q2 2019 Aug 09, 2019	SELL	$166.7 - $195.41 $1.45 Million - $1.7 Million	-8,704 Reduced 20.22%	34,332 $6.33 Million
Q1 2019 Apr 24, 2019	SELL	$180.87 - $203.88 $136,556 - $153,929	-755 Reduced 1.72%	43,036 $8.18 Million
Q4 2018 Jan 30, 2019	BUY	$178.4 - $208.25 $561,960 - $655,987	3,150 Added 7.75%	43,791 $8.53 Million
Q3 2018 Oct 26, 2018	SELL	$185.29 - $208.89 $123,217 - $138,911	-665 Reduced 1.61%	40,641 $8.42 Million
Q2 2018 Aug 10, 2018	BUY	$166.05 - $186.51 $107,102 - $120,298	645 Added 1.59%	41,306 $7.63 Million
Q1 2018 May 09, 2018	BUY	$169.43 - $198.0 $380,539 - $444,708	2,246 Added 5.85%	40,661 $6.93 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $6.43 Million - $7.34 Million	38,415	38,415 $7.16 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.

Account

Oppenheimer Asset Management Inc. Amgen Inc Transaction History